Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001104659-25-102958
Filing Date
2025-10-28
Accepted
2025-10-28 10:28:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A tm2529486d2_sc14d9a.htm SC 14D9/A 20217
  Complete submission text file 0001104659-25-102958.txt   22134
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filed by) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Subject) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-92543 | Film No.: 251421980
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)